HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cutamesine Overcomes REM Sleep Deprivation-Induced Memory Loss: Relationship to Sigma-1 Receptor Occupancy.

AbstractPURPOSE:
Rapid eye movement (REM) sleep deprivation (SD) decreases cerebral sigma-1 receptor expression and causes cognitive deficits. Sigma-1 agonists are cognitive enhancers. Here, we investigate the effect of cutamesine treatment in the REM SD model.
PROCEDURES:
Sigma-1 receptor occupancy (RO) in the rat brain by cutamesine was determined using 1-[2-(3,4-dimethoxyphenethyl)]-4-(3-phenylpropyl)piperazine ([(11)C]SA4503) and positron emission tomography (PET), and tissue cutamesine levels were measured by ultra performance liquid chromatography (UPLC)-MS. RO was calculated from a Cunningham-Lassen plot, based on the total distribution volume of [(11)C]SA4503 determined by Logan graphical analysis. Cognitive performance was assessed using the passive avoidance (PA) test.
RESULTS:
Cutamesine at a dose of 1.0 mg/kg reversed REM SD-induced cognitive deficit and occupied 92 % of the sigma-1 receptor population. A lower dose (0.3 mg/kg) occupied 88 % of the receptors but did not significantly improve cognition.
CONCLUSION:
The anti-amnesic effect of cutamesine in this animal model may be related to longer exposure at a higher dose and/or drug binding to secondary targets.
AuthorsNisha K Ramakrishnan, Marianne Schepers, Gert Luurtsema, Csaba J Nyakas, Philip H Elsinga, Kiichi Ishiwata, Rudi A J O Dierckx, Aren van Waarde
JournalMolecular imaging and biology (Mol Imaging Biol) Vol. 17 Issue 3 Pg. 364-72 (Jun 2015) ISSN: 1860-2002 [Electronic] United States
PMID25449772 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Piperazines
  • Receptors, sigma
  • sigma-1 receptor
  • Citalopram
  • SA 4503
Topics
  • Animals
  • Brain (diagnostic imaging, metabolism)
  • Chromatography, High Pressure Liquid (methods)
  • Citalopram (therapeutic use)
  • Cognition
  • Male
  • Mass Spectrometry
  • Memory Disorders (drug therapy)
  • Piperazines (chemistry)
  • Positron-Emission Tomography
  • Protein Binding
  • Rats
  • Rats, Wistar
  • Receptors, sigma (agonists)
  • Sleep Deprivation (drug therapy)
  • Sleep, REM (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: